Menu
← Oncology Approval Tracker
FDA DECISION ·
Opdivo + Yervoy
nivolumab + ipilimumab · Bristol Myers Squibb
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First-line treatment for adults with unresectable malignant pleural mesothelioma.
LAMPGEN ANALYSIS
Why it matters
Established dual checkpoint blockade as a first-line treatment option in this disease.
What research teams should watch
Document histology and resectability and plan management for lung symptoms that may reflect disease or immune toxicity.
PRIMARY RECORDS